Letter re: Oral health is an important issue in end-of-life care, December 2012

Adkinson, Lucy; Hussain, Jamilla; Daniel, Sunitha; Oxberry, Stephen G

doi:10.1007/s00520-013-1992-3

Cited by 2 publications

(4 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In two of the included studies, patients reported a mean equivalent range on a VAS 0-100 mm scale of 32 to 88 [17,20]. A published letter of response to the authors by our group outlined the burden of this condition and lack of consensus on the management in the Yorkshire region [12]. A consensus report based on a literature review in 2010 recommended that management of xerostomia in cancer patients from salivary gland dysfunction should be individualized.…”

Section: Discussionmentioning

confidence: 97%

“…The peer-reviewed survey performed by our research group found that xerostomia is a major problem in palliative care patients, and none of the interventions currently used were regarded to be effective or very effective [12]. A recently published cross-sectional study in cancer patients reported that xerostomia received the second highest mean score on a modified Edmonton Symptom Assessment Scale (ESAS) after fatigue [13].…”

Section: Introductionmentioning

confidence: 98%

See 1 more Smart Citation

Systematic literature review: xerostomia in advanced cancer patients

Hanchanale

Adkinson

Daniel

et al. 2014

Support Care Cancer

Self Cite

View full text Add to dashboard Cite

Limited published data exists reporting the effectiveness of measures in the treatment of xerostomia in cancer patients. Based on primary research of low quality, firm conclusions cannot be drawn. However, pilocarpine, artificial saliva, chewing gum and acupuncture can be tried based on the available data. This highlights the explicit need to improve our evidence base. Properly constructed randomized controlled trials demonstrating effectiveness of pharmacological and non-pharmacological interventions for dry mouth are required.

show abstract

Section: Discussionmentioning

confidence: 97%

Section: Introductionmentioning

confidence: 98%

Systematic literature review: xerostomia in advanced cancer patients

Hanchanale

Adkinson

Daniel

et al. 2014

Support Care Cancer

Self Cite

View full text Add to dashboard Cite

show abstract

“…Glycerol has a "drying action" on the oral mucosa [41]. Lemon is acidic (ascorbic, citric acid) and should not be used in patients with salivary gland hypofunction/SGH (especially dentate patients)-acidic products cause oral discomfort and promote dental demineralisation ("erosion"), dental caries and oral candidosis [1] Acidic artificial salivas Xerostomia [38] Acidic products should not be used in patients with SGH (see above) Pineapple chunks…”

Section: Patients With Resistant Oral Problems Should Be Referred To ...mentioning

confidence: 99%

“…Dirty mouth [42] Xerostomia [37,38,42] Pineapple is acidic (ascorbic acid), and such products should not be used in patients with SGH Vitamin C tablets Dirty mouth/teeth [39,42] Xerostomia [43] Vitamin C tablets are acidic (ascorbic acid, often with citric acid), and such products should not be used in patients with SGH Sweets/candies Xerostomia Sweets/candies contain sugars, which cause dental caries (especially in patients with SGH) Sweets/candies may be acidic, and such products should not be used in patients with SGH…”

Section: Patients With Resistant Oral Problems Should Be Referred To ...mentioning

confidence: 99%

MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancer

Jones

Chávarri‐Guerra

Corrêa

et al. 2022

Support Care Cancer

View full text Add to dashboard Cite

Purpose The Palliative Care Study Group in conjunction with the Oral Care Study Group of the Multinational Association for Supportive Care in Cancer (MASCC) formed a sub-group to develop evidence-based guidance on the management of common oral problems in patients with advanced cancer. Methods This guidance was developed in accordance with the MASCC Guidelines Policy. A search strategy for Medline was developed, and the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials were explored for relevant reviews and trials, respectively. Guidance was categorised by the level of evidence, and “category of guideline” (i.e., “recommendation”, “suggestion” or “no guideline possible”). Results Twelve generic suggestions (level of evidence – 5), three problem-specific recommendations and 14 problem-specific suggestions were generated. The generic suggestions relate to oral hygiene measures, assessment of problems, principles of management, re-assessment of problems and the role of dental/oral medicine professionals. Conclusions This guidance provides a framework for the management of common oral problems in patients with advanced cancer, although every patient requires individualised management.

show abstract

Letter re: Oral health is an important issue in end-of-life care, December 2012

Cited by 2 publications

References 2 publications

Systematic literature review: xerostomia in advanced cancer patients

Systematic literature review: xerostomia in advanced cancer patients

MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancer

Contact Info

Product

Resources

About